Subcutaneous Lidocaine Injection in Acute Herpes Zoster Neuralgia and Post-herpetic Neuralgia
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorAnkara City Hospital Bilkent
About this trial
In this study, it was aimed to compare the effect of subcutaneous lidocaine injection, which is routinely applied in pain clinic,in patients who present with pain complaints due to acute herpes zoster and post-herpetic neuralgia, and investigate its contribution to preventing the development of post-herpetic neuralgia
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
patients over the age of 18
with acute HZ pain (rash duration < 30 days
pain due to PHN (rash duration > 3 months),
Disqualifiers
None
Trial design
Design model
Single group
Treatments tested in this trial
Lidocaine (drug)
Procedure/SurgeryLidocain subcuteous infiltratyion will be done to rush area.
Treatment groups
76 Participants
are divided into 1 treatment groupGroup A: Patients who are referred from the dermatology clinic or voluntarily present to our pain managementActive comparator 1 intervention
Trial outcomes
Primary outcomes
1
NRS , DN4
The patients' pain scores will be assessed before treatment using the NRS (Numerical Rating Scale) and DN4 (Douleur Neuropathique en 4 Questions) pain scales. During the treatment process, patients will receive three injections, one week apart, and the NRS and DN4 pain scores will be reassessed one week after each injection.
Time frame
1st week after injectionSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: